المؤلفون: Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C Hassel, Selma Ugurel, Lisa Zimmer, Patricia Banks, Lavinia Spain, Jennifer A Soon, Tomohiro Enokida, Makoto Tahara, Katharina C Kähler, Ruth Seggewiss-Bernhardt, Catriona Harvey, Georgina V Long, Florian Schöberl, Louisa von Baumgarten, Thomas Hundsberger, Max Schlaak, Lars E French, Samuel Knauss, Lucie M Heinzerling

المصدر: Data in Brief, Vol 45, Iss , Pp 108649- (2022)

مصطلحات موضوعية: Immunotherapy, Cancer, Immune related adverse events, Neurotoxicity, Encephalitis, Anti-LGI1 encephalitis, Computer applications to medicine. Medical informatics, R858-859.7, Science (General), Q1-390

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S235234092200854XTest; https://doaj.org/toc/2352-3409Test

الوصول الحر: https://doaj.org/article/c91a9542a832459593f5a6f29e793e54Test

المؤلفون: Maartje W. Rohaan, Troels H. Borch, Joost H. van den Berg, Özcan Met, Rob Kessels, Marnix H. Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H. Beijnen, Marten Hansen, Carlijn Voermans, Inge M. Noringriis, Tine J. Monberg, Rikke B. Holmstroem, Lidwina D.V. Wever, Marloes van Dijk, Lindsay G. Grijpink-Ongering, Ludy H.M. Valkenet, Alejandro Torres Acosta, Matthias Karger, Jessica S.W. Borgers, Renske M.T. ten Ham, Valesca P. Retèl, Wim H. van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A.M. van der Veldt, Geke A.P. Hospers, Marion A.M. Stevense-den Boer, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Djura Piersma, Alfons J.M. van den Eertwegh, Jan-Willem B. de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J. Boers-Sonderen, W. Edward Fiets, Franchette W.P.J. van den Berkmortel, Eva Ellebaek, Lisbet R. Hölmich, Alexander C.J. van Akkooi, Winan J. van Houdt, Michel W.J.M. Wouters, Johannes V. van Thienen, Christian U. Blank, Aafke Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N. Schumacher, Marco Donia, Inge Marie Svane, John B.A.G. Haanen

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Biochemistry, CCA - Cancer Treatment and Quality of Life, AII - Cancer immunology, Landsteiner Laboratory, General Internal Medicine, Health Technology & Services Research, Health Technology Assessment (HTA), Medical Oncology, Erasmus MC other, Surgery, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 387, 2113-2125
New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, ' Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma. ', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125 . https://doi.org/10.1056/NEJMoa2210233Test
The New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOCIETY
The New England Journal of Medicine, 387, 23, pp. 2113-2125

مصطلحات موضوعية: Adoptive, Cell- and Tissue-Based Therapy, Outcomes, Dermatology, Metastatic melanoma, Guidelines, Immunotherapy, Adoptive, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Lymphocytes, Tumor-Infiltrating, SDG 3 - Good Health and Well-being, Adoption, Humans, Melanoma/drug therapy, Lymphocytes, Tumor-Infiltrating, Melanoma, Skin Cancer, Treatments in Oncology, Cancer, General Medicine, Complete responses, Hematology/Oncology, Ipilimumab, n/a OA procedure, Adoptive cell therapy, Nivolumab, Ipilimumab/adverse effects, Immunotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf28a71e5a16116e2b0f59cdac9485aTest
https://research.rug.nl/en/publications/9033fdbd-9e6f-4cca-a35b-50890da9f292Test

المؤلفون: Debbie van Baarle, Nynke Y. Rots, Mathilda Jalving, Christian U. Blank, Elisabeth G.E. de Vries, Guus F. Rimmelzwaan, Tatjana T Westphal, Cecile A C M van Els, Anne-Marie C. Dingemans, John B. A. G. Haanen, T. Jeroen N. Hiltermann, Egbert F. Smit, Rudolf S N Fehrmann, Arkajyoti Bhattacharya, Rob van Binnendijk, Astrid A M van der Veldt, Gerco den Hartog, Anke Huckriede, Pia Kvistborg, Corine H. GeurtsvanKessel, Sjoukje F. Oosting, Marion Koopmans, Marieke van der Heiden

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON), Microbes in Health and Disease (MHD), Medical Oncology, Radiology & Nuclear Medicine, Virology, Pulmonary Medicine

المصدر: Lancet Oncology, 22(12), 1681-1691. ELSEVIER SCIENCE INC
The Lancet Oncology, 22(12), 1681-1691. Lancet Publishing Group
The Lancet. Oncology

مصطلحات موضوعية: Male, medicine.medical_specialty, Antineoplastic Agents, Antibodies, Viral, Injections, Intramuscular, Cohort Studies, Immunomodulation, Interferon-gamma, Immunogenicity, Vaccine, SDG 3 - Good Health and Well-being, Chemoimmunotherapy, Neoplasms, Surveys and Questionnaires, VACCINES, Internal medicine, medicine, Clinical endpoint, Humans, Prospective Studies, Seroconversion, Adverse effect, Aged, Netherlands, SARS-CoV-2, business.industry, Vaccination, COVID-19, Cancer, Articles, Middle Aged, medicine.disease, Combined Modality Therapy, CANCER, Oncology, Cohort, Female, Immunotherapy, business, Febrile neutropenia, 2019-nCoV Vaccine mRNA-1273, RESPONSES

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b729685410a8953022f09c2f02822a62Test
https://doi.org/10.1016/s1470-2045Test(21)00574-x

المؤلفون: Simone Brokamp, Annegien Broeks, Christian U. Blank, Petra Herzig, Marlous van den Braber, Daniela S. Thommen, Alfred Zippelius, Marjolein de Bruijn, Joyce Sanders, Ton N. Schumacher, Lisanne M. Roelofsen, Koen J. Hartemink, John B. A. G. Haanen, Kim Monkhorst, Paula Voabil, Sanne H. Hendriks

المصدر: Nature Medicine. 27:1250-1261

مصطلحات موضوعية: business.industry, medicine.medical_treatment, Cell, Cancer, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Blockade, medicine.anatomical_structure, Immune system, Cell culture, medicine, Cancer research, Pd 1 blockade, business, Ex vivo

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c45c19b51a9c099f12311a77da46c458Test
https://doi.org/10.1038/s41591-021-01398-3Test

المؤلفون: Djura Piersma, Marye J Boers-Sonderen, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Christian U. Blank, Roos S. van Rijn, Astrid A M van der Veldt, Jan-Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jesper van Breeschoten, Doranne L. Hilarius, Bert-Jan J. ten Tije, Michel W.J.M. Wouters, Art Vreugdenhil, John B. A. G. Haanen, Maureen J.B. Aarts, Willeke A. M. Blokx

المصدر: Br J Cancer

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, business.industry, First line, Anti pd 1, Mutant, Correction, Cancer, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Survival analysis, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec07bf292a49af842f52b06a5d9be0e0Test
https://doi.org/10.1038/s41416-022-01772-zTest

المؤلفون: Joris L. Vos, Joris B. W. Elbers, Oscar Krijgsman, Joleen J. H. Traets, Xiaohang Qiao, Anne M. van der Leun, Yoni Lubeck, Iris M. Seignette, Laura A. Smit, Stefan M. Willems, Michiel W. M. van den Brekel, Richard Dirven, M. Baris Karakullukcu, Luc Karssemakers, W. Martin C. Klop, Peter J. F. M. Lohuis, Willem H. Schreuder, Ludi E. Smeele, Lilly-Ann van der Velden, I. Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V. Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B. A. G. Haanen, Charlotte L. Zuur

المساهمون: Pathology, Otolaryngology / Head & Neck Surgery, Oral and Maxillofacial Surgery / Oral Pathology, Radiology and nuclear medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, RS: GROW - R2 - Basic and Translational Cancer Biology, MUMC+: MA Keel Neus Oorheelkunde (9), KNO, AII - Amsterdam institute for Infection and Immunity, Graduate School, Oral and Maxillofacial Surgery, Other Research, CCA - Cancer Treatment and Quality of Life, Radiotherapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: Nature Communications, 12(1). NATURE PORTFOLIO
Nature Communications, 12(1):7348. Nature Publishing Group UK
Nature Communications, 12(1):7348. Nature Publishing Group
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications
Nature communications, 12(1):7348. Nature Publishing Group
Vos, J L, Elbers, J B W, Krijgsman, O, Traets, J J H, Qiao, X, van der Leun, A M, Lubeck, Y, Seignette, I M, Smit, L A, Willems, S M, van den Brekel, M W M, Dirven, R, Baris Karakullukcu, M, Karssemakers, L, Klop, W M C, Lohuis, P J F M, Schreuder, W H, Smeele, L E, van der Velden, L-A, Bing Tan, I, Onderwater, S, Jasperse, B, Vogel, W V, Al-Mamgani, A, Keijser, A, van der Noort, V, Broeks, A, Hooijberg, E, Peeper, D S, Schumacher, T N, Blank, C U, de Boer, J P, Haanen, J B A G & Zuur, C L 2021, ' Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma ', Nature Communications, vol. 12, no. 1, 7348, pp. 7348 . https://doi.org/10.1038/s41467-021-26472-9Test

مصطلحات موضوعية: Male, Science, SALVAGE SURGERY, General Physics and Astronomy, Article, Phase II trials, General Biochemistry, Genetics and Molecular Biology, Fluorodeoxyglucose F18, Exome Sequencing, Biomarkers, Tumor, Humans, RECURRENT, Head and neck cancer, Immune Checkpoint Inhibitors, Aged, Multidisciplinary, MUTAGENESIS, Squamous Cell Carcinoma of Head and Neck, APOBEC, General Chemistry, Middle Aged, Translational research, CHEMOTHERAPY, OPEN-LABEL, Ipilimumab, CANCER, Neoadjuvant Therapy, stomatognathic diseases, Nivolumab, DURVALUMAB, TREMELIMUMAB, Head and Neck Neoplasms, Positron-Emission Tomography, Tumour immunology, Female, Immunotherapy, RADIOTHERAPY

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500e65e4a1d2b65013f14d4e0fa7a71fTest
http://hdl.handle.net/1887/3279830Test

المؤلفون: Rutger H. T. Koornstra, Sandrine Marreaud, Victoria Atkinson, Andrey Meshcheryakov, Christian U. Blank, Piotr Rutkowski, Jean-Jacques Grob, Leonel Hernandez-Aya, Clemens Krepler, Michal Kicinski, Dirk Schadendorf, Paolo A. Ascierto, Caroline Robert, Mario Mandalà, Susana Puig, Nageatte Ibrahim, Alexander C.J. van Akkooi, Adnan Khattak, Stéphane Dalle, Georgina V. Long, James Larkin, Shahneen Sandhu, Rahima Jamal, Matteo S. Carlino, Alfonsus J M van den Eertwegh, Ralf Gutzmer, Anna Maria Di Giacomo, Andrew Haydon, Alexander M.M. Eggermont, Stefan Suciu, Paul Lorigan

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85Test
https://hdl.handle.net/2066/228545Test

المؤلفون: Jan Willem B. de Groot, Djura Piersma, John B. A. G. Haanen, Astrid A M van der Veldt, Alfonsus J. M. van den Eertwegh, Christian U. Blank, Gerard Vreugdenhil, Ellen Kapiteijn, Esther Bastiaannet, Monique K van der Kooij, Miranda P Dierselhuis, Marye J Boers-Sonderen, Karijn P M Suijkerbuijk, Albert J. ten Tije, Franchette W P J van den Berkmortel, Marjolein J A L Wetzels, Maureen J.B. Aarts, Rozemarijn S. van Rijn, Michel W.J.M. Wouters, Geke A. P. Hospers

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: van der Kooij, M K, Wetzels, M J A L, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, Dierselhuis, M P, de Groot, J W B, Hospers, G A P, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Haanen, J B A G, van den Eertwegh, A J M, Bastiaannet, E & Kapiteijn, E 2020, ' Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response ', Cancers, vol. 12, no. 8, 2072, pp. 1-15 . https://doi.org/10.3390/cancers12082072Test
Cancers, 12(8):2072, 1-15. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12, 8
Cancers, 12
Cancers
Cancers, 12(8):2072. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12(8):2072, 1-15. MDPI AG
Cancers, Vol 12, Iss 2072, p 2072 (2020)
Cancers, 12(8). MDPI

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, advanced melanoma, young adults, Cancer Research, medicine.medical_specialty, AYA, microbiome, open-label, lcsh:RC254-282, survival, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, METASTATIC MELANOMA, Cumulative incidence, adolescents, Young adult, ipilimumab, Adverse effect, PEMBROLIZUMAB, risk, nivolumab, business.industry, MUTATIONS, prospective nation-wide data, Melanoma, Hazard ratio, clinical audit, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, targeted therapy, humanities, Clinical trial, BRAF mutation, Oncology, 030220 oncology & carcinogenesis, choice chemotherapy, outcome research, business, checkpoint inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7e43ad335ec2975ce6222cf027b69dTest
https://doi.org/10.3390/cancers12082072Test

المؤلفون: Sanne Patiwael, Christian U. Blank, Ton N. Schumacher, Antoni Ribas, John B. A. G. Haanen, Anastasia Gangaev, Daisy Philips, Dirk Schadendorf, Joost H. van den Berg, Maartje W. Rohaan, Bastian Schilling, Elisa A. Rozeman, Pia Kvistborg, Olga I. Isaeva

المصدر: Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences of the United States of America, vol 118, iss 43

مصطلحات موضوعية: Male, Receptors, Antigen, T-Cell, alpha-beta, Programmed Cell Death 1 Receptor, Medizin, Epitopes, T-Lymphocyte, CD8-Positive T-Lymphocytes, Lymphocyte Activation, Epitope, Cohort Studies, Epitopes, melanoma-reactive CD8 T cells, Receptors, PD-1, 80 and over, Cytotoxic T cell, CTLA-4 Antigen, Hepatitis A Virus Cellular Receptor 2, Immune Checkpoint Inhibitors, Melanoma, Cancer, alpha-beta, Aged, 80 and over, Multidisciplinary, Middle Aged, Biological Sciences, medicine.anatomical_structure, 5.1 Pharmaceuticals, Antigen, Female, Development of treatments and therapeutic interventions, medicine.symptom, Melanoma-Specific Antigens, Adult, Receptors, CXCR5, T cell, In Vitro Techniques, Clinical Research, medicine, Humans, Aged, business.industry, Compartment (ship), T-Cell, medicine.disease, CXCR5, Blockade, Kinetics, T-Lymphocyte, Mechanism of action, CTLA-4, Cancer research, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994323e563648a11d8ffa0127b701604Test
https://doi.org/10.1073/pnas.2102849118Test

المؤلفون: Michel W.J.M. Wouters, Marion Stevense, Ellen Kapiteijn, Christian U. Blank, Karijn P M Suijkerbuijk, Astrid Aplonia Maria Van Der Veldt, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil, Maureen J.B. Aarts, Liesbeth C. de Wreede, Jesper van Breeschoten, Erik W. van Zwet, John B. A. G. Haanen, Jan Willem B. de Groot, Franchette W P J van den Berkmortel, Marye Boers-Sonderen, Doranne L. Hilarius

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Medical Oncology, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: Cancers, 13(20):5077. MDPI AG
Cancers, 13, 20
van Breeschoten, J, van den Eertwegh, A J M, de Wreede, L C, Hilarius, D L, van Zwet, E W, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-sonderen, M J, Suijkerbuijk, K P M & Wouters, M W J M 2021, ' Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients : Nationwide quality assurance in the netherlands ', Cancers, vol. 13, no. 20, 5077 . https://doi.org/10.3390/cancers13205077Test
Cancers, 13(20):5077. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 5077, p 5077 (2021)
Cancers, 13(20). MDPI
Cancers
Volume 13
Issue 20
Cancers, 13

مصطلحات موضوعية: Oncology, advanced melanoma, Cancer Research, medicine.medical_specialty, Metastatic melanoma, IMPACT, MULTICENTER, survival, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, medicine, METASTATIC MELANOMA, Quality of care, RC254-282, Advanced melanoma, business.industry, center variation, Melanoma, Significant difference, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, Random effects model, DABRAFENIB, Stage iv melanoma, business, Quality assurance

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d369fca07c88bdc71e6f5d5567757c91Test
https://hdl.handle.net/11370/144a687b-1f76-44fd-acca-1d9813cd82c3Test